Scinai Immunotherapeutics (SCNI) Non-Current Assets (2017 - 2025)

Scinai Immunotherapeutics has disclosed Non-Current Assets across 9 years of filings, most recently posting $9.6 million for Q4 2025.

• Non-Current Assets for Q4 2025 came in at $9.6 million, down 13.43% year-over-year; the trailing twelve-month figure through Dec 2025 was $9.6 million (down 13.43% YoY), and the FY2025 annual result was $9.6 million, down 13.43% from the prior year.
• Non-Current Assets came in at $9.6 million for Q4 2025 at Scinai Immunotherapeutics, down from $10.3 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $14.2 million in Q4 2021 to a low of $9.6 million in Q4 2025.
• The 5-year median for Non-Current Assets is $12.0 million (2023), against an average of $11.9 million.
• Across the five-year window, Non-Current Assets rose 1.4% in 2021 and dropped 13.43% in 2025, its largest moves.
• Scinai Immunotherapeutics' Non-Current Assets stood at $14.2 million in 2021, then slipped by 10.54% to $12.7 million in 2022, then dropped by 5.29% to $12.0 million in 2023, then declined by 8.05% to $11.1 million in 2024, then decreased by 13.43% to $9.6 million in 2025.
• The last three Non-Current Assets figures came in at $9.6 million (Q4 2025), $10.3 million (Q2 2025), and $11.1 million (Q4 2024), per Business Quant data.